Brian I. Rini – författare

Whether you're a newly diagnosed patient or a friend or relative of someone suffering from kidney cancer, this book can help. Offering both doctor and patient perspectives, Questions amp Answers About Kidney Cancer, Second Edition provides authoritative and practical answers to the most commonly asked questions by patients and their loved ones. What is kidney cancer? What causes kidney cancer? How is kidney cancer treated?Along with the answers to these and other questions, this book provides information on the different types of kidney cancer, signs and symptoms, treatment options, and more. Written by experts in the field Questions amp Answers About Kidney Cancer, Second Edition is an invaluable resource for anyone coping with the physical and emotional uncertainty of this disease.

According to the American Cancer Society, kidney cancer is one of the ten most common cancers in both men and women. No one with kidney cancer needs to be alone in their fight against this disease. That's where this book and the information within can help! 100 Questions & Answers About Kidney Cancer, Fourth Edition offers authoritative and practical answers to the most common questions asked by patients and their loved ones. What is kidney cancer? What causes kidney cancer? How is kidney cancer treated?The authors bring their vast experience, expertise, and cutting-edge research in the field to answer these and other questions. They provide information on different types of kidney cancer, signs and symptoms, treatment options, and more. 100 Questions & Answers About Kidney Cancer, Fourth Edition is an invaluable resource for anyone coping with the physical and emotional uncertainty of this disease.NEW to THIS EDITION:- New section (Part 10) brings together and summarizes all of the treatments that are now being utilized for patients with metastatic kidney cancer.- New summary of the most recent recommendations from the National Comprehensive Cancer Network (NCCN), a leading source of up-to-date cancer treatment recommendations, regarding systemic treatments for metastatic kidney cancer (Appendix).

This book provides a comprehensive look at renal cell carcinoma, exploring its biology as well as current and future molecular targets for renal cancer carcinoma.

This book provides a comprehensive look at renal cell carcinoma, exploring its biology as well as current and future molecular targets for renal cancer carcinoma.

This book provides a comprehensive look at renal cell carcinoma, exploring its biology as well as current and future molecular targets for renal cancer carcinoma.

The volume reviews new data about risk factors for the disease, profiles the new staging system for renal cell carcinoma (RCC), highlights our current understanding of familial syndromes of RCC and their molecular genetics, and provides new perspectives about imaging of renal tumors.

Renal Cell Carcinoma: Clinical Management provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in kidney cancer. The volume reviews new data about risk factors for the disease, profiles the new staging system for renal cell carcinoma (RCC), highlights our current understanding of familial syndromes of RCC and their molecular genetics, and provides new perspectives about imaging of renal tumors. For localized disease, a greater appreciation of nephron-sparing approaches and the importance of preservation of renal function is discussed in detail. Advances in surgical techniques are highlighted. For metastatic disease, the molecular biology of kidney cancer is reviewed in a concise and understandable manner, including the data that has fostered novel targeted approaches that have revolutionized management. The several landmark phase III targeted therapy trials published in the last few years are placed in context with respect to current management. Integration of surgery and systemic therapy through cytoreductive and consolidative approaches has yielded provocative data that promises to further advance the field, and major advances in this domain are also be discussed.